Chester County News and Community Website
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has announced its financial results for the second quarter ending June 30, 2024, along with significant business updates. The company highlighted positive …
Annovis Bio Reports Q2 2024 Financial Results and Business Progress Read More
NEWTOWN, PA — Traws Pharma, Inc. announced its second quarter 2024 financial results and highlighted key developments following its merger with Trawsfynydd Therapeutics. The merger, completed in April, included a …
Traws Pharma Reports Q2 Financials and Merger with Trawsfynydd Therapeutics Read More
LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) reported record revenue of $1.44 million for the second quarter of 2024, representing a 23.4% year-over-year increase. The company’s growth was driven significantly …
NEXGEL Announces Record Second Quarter Revenue and Strategic Developments Read More
HORSHAM, PA — STRATA Skin Sciences, Inc. (NASDAQ: SSKN) has announced its financial results for the quarter ended June 30, 2024, along with notable corporate updates.
STRATA Skin Sciences Reports Second Quarter 2024 Financial Results and Strategic Progress Read More
NEWTOWN SQUARE, PA — ArriVent BioPharma, Inc. (Nasdaq: AVBP) has announced its financial results for the second quarter of 2024, alongside significant advancements in its oncology pipeline and recent corporate …
ArriVent BioPharma Reports Strong Second Quarter and Highlights Progress Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced its financial results this week for the second quarter ended June 30, 2024, reporting net revenue of $4.9 million for …
Verrica Pharmaceuticals Reports Steady Growth with Q2 Financial Results Read More
RADNOR, PA — Mineralys Therapeutics, Inc. (Nasdaq: MLYS) this week announced its financial results for the second quarter ending June 30, 2024, and provided a corporate update, highlighting significant progress …
Mineralys Therapeutics Posts Q2 Financial Results, Updates on Clinical Trials Read More
NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) recently reported its financial results for the second quarter ended June 30, 2024, alongside significant business developments. The company is …
Orchestra BioMed Holdings Reports Second Quarter 2024 Financial Results and Business Updates Read More
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has released its financial and operational results for the second quarter of 2024, marking a period of strategic initiatives and significant developments in …
Neuronetics Reports Second Quarter 2024 Financial Results and Strategic Developments Read More
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) has reported its financial results for the second quarter ended June 30, 2024. The company showcased notable revenue growth and significant strategic …
TELA Bio Announces Second Quarter 2024 Financial Results and Strategic Developments Read More